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Abstract
The in vitro process of chondrogenic differentiation of mesenchymal stem cells for tissue engineering has been shown to
require three-dimensional culture along with the addition of differentiation factors to the culture medium. In general, this
leads to a phenotype lacking some of the cardinal features of native articular chondrocytes and their extracellular matrix.
The factors used vary, but regularly include members of the transforming growth factor b superfamily and dexamethasone,
sometimes in conjunction with fibroblast growth factor 2 and insulin-like growth factor 1, however the use of soluble
factors to induce chondrogenesis has largely been studied on a single factor basis. In the present study we combined a
factorial quality-by-design experiment with high-throughput mRNA profiling of a customized chondrogenesis related gene
set as a tool to study in vitro chondrogenesis of human bone marrow derived mesenchymal stem cells in alginate. 48
different conditions of transforming growth factor b 1, 2 and 3, bone morphogenetic protein 2, 4 and 6, dexamethasone,
insulin-like growth factor 1, fibroblast growth factor 2 and cell seeding density were included in the experiment. The
analysis revealed that the best of the tested differentiation cocktails included transforming growth factor b 1 and
dexamethasone. Dexamethasone acted in synergy with transforming growth factor b 1 by increasing many chondrogenic
markers while directly downregulating expression of the pro-osteogenic gene osteocalcin. However, all factors beneficial to
the expression of desirable hyaline cartilage markers also induced undesirable molecules, indicating that perfect
chondrogenic differentiation is not achievable with the current differentiation protocols.
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Introduction
Mesenchymal stem cells (MSCs) have been advocated as a
useful cell source for tissue engineering. MSCs were originally
isolated from bone marrow, but have later been found in and
isolated from numerous tissues [1,2]. They can be readily
expanded in vitro and differentiated into tissues of mesodermal
and, in some instances, ectodermal lineages [3,4]. Clinically MSCs
have shown promising potential in treatments of graft-versus-host-
disease and in repair of full-thickness cartilage defects [5,6].
The in vitro process of directed differentiation of mesenchymal
stem cells has been widely studied. Chondrogenic differentiation of
MSCs has been shown to require the use of either high-density cell
pellet, micro-mass cultures or a scaffold allowing for three-
dimensional culture [7–9] along with the addition of differentia-
tion factors to the culture medium [10–13].
The differentiation factors have traditionally included factors
from the TGF superfamily such as transforming growth factor b
(TGFb) [7,14,15] and/or bone morphogenetic protein (BMP)
[9,16,17] along with the steroid hormone dexamethasone (DEX).
Other factors used are fibroblast growth factor 2 (FGF2)
[15,18,19] and insulin-like growth factor 1 (IGF1) [20,21].
Traditionally, the use of soluble factors to induce chondrogenesis
has largely been studied on a single factor basis or with simple
combinations of a few factors. However, optimizing differentiation
conditions one factor at a time is time consuming, and does not
take into account interdependency between factors, which is likely
to play a role in growth factor mediated differentiation. Factorial
analysis is commonly used in industrial processes as a statistically
and scientifically sound way of analyzing interplay between several
factors on a predefined outcome. Factorial design (often termed
quality-by-design) has been used for optimization of protocols in a
variety of industries and research areas including pharmaceutical
studies and manufacturing, stem cell biology, polymer production
and tissue engineering [22–24].
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on multiple samples has been done using microarray hybridization
technology with a relative high cost per individual sample. Smaller
sets of genes have often been investigated using quantitative
polymerase chain reactions (qPCR), though upscaling of qPCR
experiments rapidly exceeds practically and economically feasible
numbers of reactions. However, the introduction of digital and
highly multiplexed mRNA-profiling (Nanostring nCounter) has
made it possible and cost-effective to analyze large number of
samples on predefined gene sets of up to 800 genes with an
accuracy equal to single-plex qPCR [25]. This may be performed
directly on cell lysates, thus bypassing the variability introduced by
RNA isolation and conversion to cDNA which is necessary in
microarrays and RT-qPCR [26].
In the present study we undertook a detailed comparison of all
possible combinations of five commonly used differentiation
factors in a fully humanized culture system: TGFb1, BMP2,
dexamethasone, FGF2 and IGF1 used for in vitro chondrogenesis
of MSCs established in 3D culture in alginate hydrogels, including
a comparison of the three isoforms of the TFGb growth factor
(TGFb1, TGFb2 and TGFb3) and three of the isoforms of BMP
(BMP2, BMP4 and BMP6). Our aim was to explore factorial
design and digital mRNA profiling as tools to characterize directed
differentiation of MSCs and to validate the most commonly used
chondrogenic growth factors.
Methods and Materials
All chemicals were purchased from Sigma-Aldrich (St. Louis,
MO) unless otherwise stated.
Ethics statement
The study including the harvest of bone marrow from voluntary
donors was approved by the Regional Committee for Medical
Research Ethics, Southern Norway. Informed written consent was
obtained from all donors before the harvest procedure.
Cell harvest and culture
Bone marrow aspirates were obtained from the iliac crest of
three healthy donors as previously described [27]. The isolation
and culture procedure is given in Appendix S1.
Medium and supplements
Growth medium for monolayer cultures contained 2 U/mL
heparin, 100 U/mL penicillin, 100 mg/mL streptomycin and
2,5 mg/mL amphotericin B in DMEM F-12, with 20% human
platelet lysate (hPL) (Appendix S1) added for the first passage and
10% for all subsequent passages.
Basic chondrogenic differentiation medium (bCDM) contained
sodium pyruvate, ascorbic acid 2-phosphate, ITS and human
serum albumin in high-glucose DMEM-F12 (4,5 g/L). bCDM was
supplemented with BMP2, BMP4 or BMP6, TGFb1, TGFb2o r
TGFb3, dexamethasone, FGF2 and/or IGF1. Working concen-
trations and suppliers of all supplements are given in Table 1.
Validation of cells as MSC
Cells used for experiments in passage 2 or 3 were validated as
MSCs by flow cytometry and differentiation assays as described in
Appendix S1 and Table S1.
3D cell culture
Cells in passage 2 or 3 were trypsinized, counted, washed in
PBS and seeded into a self-gelling alginate scaffold (NovaMatrix,
Sandvika, Norway) as described previously and in Appendix S1
[28].
Experimental design
We investigated a total of 48 different conditions (Figure 1A).
Five factors: TGFb1, IGF1, DEX, FGF2 and BMP2 were
investigated in two-level (present or not) full 2
5 factorial design
experiments. Concentrations were based on typical use in the
literature [7,15–17,21]. This gave a total of 32 conditions in each
experiment, which was repeated with cells from three donors at
two time points each: days 1 and 7. In addition a modified design
investigating TGFb isoforms 1, 2 and 3 and BMP isoforms 2, 4
and 6 was also performed, including an experiment where the cell
density was varied between 1.25610
6 and 2610
7 cells/mL at
log(2)-intervals. Design of the experiments was done with
MiniTAB Statistical Software version 16 (Minitab Inc, State
College, PA - www.minitab.com). At the end of the experiments
discs were divided in halves, snap-frozen in liquid nitrogen and
stored at 280uC. Negative control disc cultures were performed in
the same way using bCDM only, while positive controls were discs
supplemented with our to date standard chondrogenic differenti-
ation cocktail consisting of TGFb1, BMP2 and DEX, concentra-
tions are given in Table 1. Positive control samples were collected
at day 7, 14 and 21 with additions of extra discs fixed in 4%
paraformaldehyde for immunohistochemistry.
Digital mRNA profiling and quantitative polymerase
chain reaction
Frozen discs were crushed in liquid nitrogen with a pestle (Argos
Technologies, Elgin, IL), lysed in RLT buffer and homogenized
(QiaShredder, Qiagen, Venlo, Netherlands). Samples were then
either directly used for digital mRNA profiling with the Nano-
string nCounter technology [25] (NanoString Technologies,
Seattle, WA) or RNA was extracted (RNeasy Mini kit, Qiagen).
For qPCR, after DNase I treatment (Ambion; Life Technologies,
Carlsbad, CA), reverse transcription (RT) was performed accord-
ing to protocol (High-Capacity cDNA archive Kit; Applied
Biosystems, Foster City, CA) using 200 ng total RNA per RT
reaction and analyzed with the primers for peroxisome prolif-
erator-activated receptor gamma and osteomodulin (PPARG
Hs01115513_m1, OMD Hs00192325_m1, Applied Biosystems).
For the digital mRNA profiling, a custom chondrogenic gene set
consisting of 364 genes (Appendix S2) including endogenous
controls was established on the background of genes known or
suspected to be affected by chondroskeletogenesis. We used a
previous study from our lab of differentially expressed genes in the
course of chondrogenic differentiation of MSCs to select genes
based predominantly on the level of differential expression. These
were supplemented with genes chosen from previously published
papers from other labs describing genes known to be involved in
chondrogenesis [28–31]. For analysis of lysate vs. purified mRNA
performance, the pre-designed NanoString 48-plex Customer
Assay Evaluation (CAE) kit was used instead. Sample preparation
and hybridization was performed according to the manufacturer’s
instructions with either 100 ng of total RNA or lysate equivalent to
10.000 cells. All hybridizations were incubated at 65uC purified
and counted on the nCounter Prep Station and Digital Analyzer
(NanoString Technologies).
Data analysis and statistics
Normalization for lane-to-lane variation and positive spike-in-
control series were performed according to the manufacturer’s
protocol using Microsoft Excel (Microsoft, Redmond, WA) [32].
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identified by NormFinder was used to normalize the data [33].
Further data normalization was performed in the R statistical
application (http://www.R-project.org/) including log transfor-
mation using the "vsn" package [34].
The MiniTAB Statistical Software package was used to fit a
statistical regression model to analyze main effects, two and three
factor interactions with significance assumed for p-values less than
0.05 in a multivariate analysis of variance on the normalized data.
If needed, transformation of the responses was used to make the
residuals exhibit normality as judged by normality plots. Pearson’s
correlation between expression values in lysates and RNA and
Spearman’s correlation between rankings of conditions day 1 and
day 7 were calculated with Prism 6 (Graphpad, San Diego, CA).
To make graphical representations of wanted and unwanted
genes the data were normalized by Studentization, ie. subtracting
the mean expression of each gene across all conditions divided by
the standard deviation. For analysis of significantly changed genes
and gene set enrichment analysis the data were analyzed in R
using the "Limma" package to fit a linear model to the data [35].
Cut-off values were set to twofold difference in expression values
with a false discovery rate of 5% (FDR , 0.05). The "ade4"
package in R was used to perform a two-dimensional principal
component analysis on the normalized data [36].
Results
Characterization of cells and validation of the use of
lysates for mRNA profiling
Surface antigen profiles were obtained of the expanded cells at
passage 2 (Figure S1A). Cells readily differentiated into adipogenic
and osteogenic lineages verified by extensive staining of lipid
droplets and calcium deposits and upregulation of PPARG and
OMD (Figure S1B and C). Cells also showed differentiation into
the chondrogenic lineage with upregulation of gene expression and
synthesis of proteins representing key chondrogenic markers
(Figure S1D and E). To evaluate if lysate of cells in alginate discs
could be used instead of RNA, lysate and RNA isolated from
matching samples at three timepoints grown under standard
chondrogenic conditions were analyzed. Results showed highly
significant correlations (p ,0.0001) for all pairs with coefficients of
determination (R
2) ranging from 0.92 to 0.97 (Figure S2). This
validated the use of lysate through the rest of the study.
Principal component analysis on the full gene set
Principal component analysis (PCA) is a powerful way of
reducing the dimensionality of a large data set in an unbiased way
to identify clustering behaviour [37]. To see if the mRNA profiling
of the full chondrogenic gene set reflected the studied conditions
both regarding factors and temporal spatialization, we performed
a PCA on the full dataset in all conditions at all timepoints
(Figure 1B). This revealed that day 1 and day 7 samples clustered
together, with larger differences observed within the day 7 cluster.
We next limited the the PCA to only day 0 (untreated cells) and
the full 2
5-factorial design at day 1 (Figure 1C) or day 7 (Figure 1D)
to allow for a more detailed analysis of the individual factors and
combinations. At both timepoints it was readily apparent that
conditions clustered according to TGFb1 exposure, with unex-
posed conditions being closer to undifferentiated MSCs. On day 7
(Figure 1D) it was also evident that adding IGF1 led to only very
minor differences (see for example conditions 25 and 27, 2 and 4
or 9 and 11). Notably, the 6 conditions found in the lower right
quadrant of the plot all included TGFb1 and DEX.
Interactions between TGFb1, DEX, BMP2, IGF1 and FGF2
evaluated by changes in selected gene subsets
The full custom-made chondrogenic gene set comprised 364
genes including endogenous reference genes. It included both
genes that are hallmarks of hyaline cartilage, but also genes that
mark other differentiation processes such as adipogenesis or
osteogenesis. To study the effects of the individual factors
specifically on chondrogenesis we prespecified two subsets of
genes: a "wanted" marker group comprised of genes coding for
extracellular matrix (ECM) molecules known to be hallmarks of
native hyaline cartilage [38], and the negative "unwanted" marker
group comprised of genes coding for extracellular molecules
distinctive for other cartilage types, but also genes coding for major
transcription factors of other lineages such as adipose tissue or
bone. These markers were selected based on descriptions of
biological functionality in a number of selected references as
described in Table 2. The mean expression of "wanted" or
"unwanted" markers was used as responses when fitting a statistical
Table 1. List of culture supplements.
Supplements Working concentration Company Catalog number
Sodium pyruvate 1 mM Gibco (Life Technologies, Carlsbad, CA) 11360
Ascorbic acid 2-phosphate 0.1 mM Sigma-Aldrich (St. Louis, MO) A8960
Insulin-transferrin-sodium selenite media supplement 1% Sigma-Aldrich (St. Louis, MO) I1884
Human serum albumin 1,25 mg/mL Baxter (Deerfield, IL) N/A
Dexamethasone 100 nM Sigma-Aldrich (St. Louis, MO) D4902
Insulin-like growth factor 1 100 ng/mL Sigma-Aldrich (St. Louis, MO) I3769
Transforming growth factor b 1 10 ng/mL R&D Systems (Minneapolis, MN) 240-B
Transforming growth factor b 2 10 ng/mL R&D Systems (Minneapolis, MN) 302-B2
Transforming growth factor b 3 10 ng/mL R&D Systems (Minneapolis, MN) 243-B3
Bone morphogenetic protein 2 500 ng/mL Wyeth (Taplow, UK) InductOs
Bone morphogenetic protein 4 500 ng/mL R&D Systems (Minneapolis, MN) 314-BP
Bone morphogenetic protein 6 500 ng/mL R&D Systems (Minneapolis, MN) 507-BP
Fibroblast growth factor 2 10 ng/mL Sigma-Aldrich (St. Louis, MO) F0291
doi:10.1371/journal.pone.0096615.t001
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study the main effects of individual factors and significant
interactions between factors on chondrogenesis. The normal plots
of standardized effects using wanted and unwanted markers on
day 1 (Figure S3A and D) and day 7 (Figure 2A and D) show the
factors and interactions that significantly affected the wanted and
unwanted responses. Focusing on day 7, TGFb1, DEX and BMP2
affected the wanted markers significantly in the desired direction
and FGF2 in the opposite direction (Figure 2B). A more complete
description is seen when analyzing the significant two-way
interactions of TGFb1 with DEX and TGFb1 with BMP2
(Figure 2C). The effect on wanted markers of TGFb1 was
dependent on the presence of DEX. TGFb1 on its own had a
much smaller effect than when added in the presence of DEX. For
the interaction of TGFb1 with BMP2 the opposite was true:
adding TGFb1 in the presence of BMP2 led to a smaller absolute
increase in wanted marker expression than when TGFb1 was
added alone (Figure 2D). Only one three-way interaction, that of
TGFb1, DEX and BMP2, was found to significantly affect wanted
markers. However, the standardized effect was small, and showed
Figure 1. Experimental setup and principal component analysis (PCA). A. Experimental setup with numbering of the different conditions.
When not stated, the cell density was 10
7 cells per mL. B. PCA on all conditions labelled by days in culture. C. PCA limited to conditions 1–32 on days
0 and 1. D. PCA limited to conditions 1–32 on days 0 and day 7.
doi:10.1371/journal.pone.0096615.g001
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was affected by the addition of the third factor, which in both cases
decreased the total effect slightly (Table S2). The effects of the
differentiation factors on the expression of the unwanted marker
genes were very similar to that seen for the wanted genes, with a
few notable differences (Figure 2E, F, G and H). First, DEX alone
did not have a significant effect (Figure 2F, Table S2). Second,
both TGFb1 and BMP2 alone increased unwanted marker
expression, but in combination TGFb1 or BMP2 did not increase
unwanted expression above that seen for each of them alone
(Figure 2G). FGF2 seemed to reduce the expression of wanted
genes considerably, while IGF1 did not impact on this gene set at
all (Figure 2B and F).
Identifying optimal differentiation conditions from the
expression of wanted and unwanted genes
As the PCA was done on the full gene set, we next wanted to
explore if the changes in gene expression that segregated the
different conditions reflected a desired change in terms of the
expression of the wanted or unwanted gene subsets (Figure 3A).
Interestingly, we found a highly significant (P , 0.0001)
correlation between the ranking of conditions on day 1 and day
7 (Figure 3B), which shows that the changes in mRNA expression
that arise soon after induction of differentiation can predict the
direction of later changes. Corroborating the PCA, and supporting
the validity of the chosen genes in the wanted and unwanted gene
groups, plots of the summary score of wanted and unwanted
markers show larger separation in the day 7 samples (Figure 3B).
In the detailed view of day 0 and the full 2
5-factorial design on day
7 (Figure 3C) it is clear that conditions 9 and 11 are the most
favorable, with low scores for unwanted markers and the highest
scores of wanted markers overall. It is also apparent from the color
coding that TGFb1 is substantially affecting expression of wanted
markers in the desired direction, yet also increasing the expression
of unwanted markers. DEX, on the other hand, seems to increase
Figure 2. Statistical analysis of main effects and interactions at day 7. A. Normal plot of the standardized effects with the response set to
mean expression of wanted markers. B. Corresponding main effects plot of all factors. C and D. Corresponding plots of significant second order
interactions. E. Normal plot of the standardized effects with the response set to mean expression of unwanted markers. F. Corresponding main
effects plot of all factors. G and H. Corresponding plots of significant second order interactions.
doi:10.1371/journal.pone.0096615.g002
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TGFb1.
To support these findings we performed a gene set enrichment
analysis for the wanted and unwanted gene sets. Conditions
significantly enriched for the wanted gene set (FDR , 0.05), but
not significantly enriched for the unwanted gene set, are
highlighted in bold sorted by the FDR (Table 3). The top ranked
conditions match the previous findings and a heatmap of the
expression of wanted and unwanted markers of the top ten
conditions (Figure 4) further visually confirms the changes with
lower expressions of unwanted markers and higher expression of
wanted markers in conditions 9, 11, 10 and 12. However, from the
heatmap it is also apparent that individual unwanted and wanted
genes such as LUM, ALPL, COL10A1 and PPARG did not change
in the desired direction.
The three TGFb isoforms tested did not show substantial
differences in the mean expression of wanted and unwanted
markers. Addition of any TGFb isoform increased both wanted
and unwanted markers, addition of DEX to any of these increased
wanted markers further and addition of BMP2 in the presence of
TGFb and DEX decreased unwanted marker expression slightly
(Figure S4A). In the comparison of BMP isoforms we found that
addition of any of the three BMP isoforms alone increased both
wanted and unwanted marker expression, and addition of TGFb1
further increased the expression of wanted markers (Figure S4B).
Cell density upon induction of chondrogenesis affected expression
both on day 1 and day 7 (Figure S4C). The expression of wanted
markers on day 7 increased as the cell density was increased from
1.25610
6 to 10610
6 cells/mL. However, further increasing the
cell density to 2610
7 cells/mL reduced the expression of wanted
genes substantially.
Genes uniformly affected by single factors across all
conditions
To elucidate effects of individual factors on genes other than the
selected wanted or unwanted marker genes we performed an
analysis of differentially expressed genes between the bCDM and
Table 2. Selected wanted and unwanted gene sets.
Gene symbol Gene name Functional role
WANTED ACAN aggrecan Major proteoglycan in hyaline cartilage
BGN biglycan Small leucine rich proteoglycans, pericellular location and links to
chondroitin sulfate in hyaline cartilage
COL11A1/2 collagen, type XI, alpha1/2 Fibril forming collagen found associated with type 2 collagen in
hyaline cartilage
COL2A1 collagen, type II, alpha 1 The major fibril forming collagen almost exclusively found in
hyaline cartilage
COL9A1/2/3 collagen, type IX, alpha 1/2/3 Fibril associated collagen with interrupted triple helix found
covalently linked to collagen type 2 in hyaline cartilage
COMP cartilage oligomeric matrix protein Prominent component in the ECM of hyaline cartilage possibly
stabilizing the collagen fibril assembly and network
DCN decorin Small leucine rich proteoglycan, binds to collagen fibrils and aids
in assembly
FMOD fibromodulin Small leucine rich proteoglycan, aids in collagen assembly in
cartilage in early development
HAPLN1 hyaluronan and proteoglycan link protein 1 Abundant protein in cartilage, stabilizes aggregates of
hyaluronan and aggrecan
LUM lumican Leucine rich proteoglycan, aids in collagen assembly in cartilage
in early development
MATN3 matrilin 3 Matrix protein restricted to cartilage and binds tightly to
aggrecan and/collagen fibrils
UNWANTED ALPL alkaline phosphatase, liver/bone/kidney Major enzyme leading to mineralization of bone
COL10A1 collagen type X, alpha 1 Network forming collagen found predominantly in hypertrophic
or diseased cartilage
COL1A1/2 collagen type I, alpha 1/2 Fibril forming cartilage abundant in bone ECM and virtually
absent in hyaline cartilage
COL3A1 collagen type III, alpha 1 Fibril forming collagen often found in mixed fibrils with collagen
type 1
OGN osteoglycin Small leucine rich proteoglycan, induces bone formation
PPARG peroxisome proliferator-activated receptor
gamma
Nuclear receptor, promotes adipogenesis, stimulates lipid uptake
and glucose metabolism
RUNX2 runt related transcription factor 2 Transcription factor required for bone formation
SP7 osterix Transcription factor essential for osteoblastogenesis
SPP1 osteopontin Bone protein, potentiates osteoclast adhesion to mineral surfaces
VCAN versican Proteoglycan present in fibrous and elastic cartilage, upregulated
in dedifferentiating chondrocytes
Gene symbol and name of all genes comprising the wanted and unwanted marker gene sets. Based on references [28,38,66–73].
doi:10.1371/journal.pone.0096615.t002
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consistently up or down regulated in all conditions with any one of
the five factors. It is evident that the expression for several genes is
completely dependent on the presence of a specific factor. The
pro-osteoblastic gene BGLAP, for example, which codes for
osteocalcin, was downregulated in all conditions containing
DEX, but not affected in any other condition. The matrix
metallopeptidase MMP1, which specifically degrades type I, II and
III collagen, was also almost exclusively downregulated in
conditions containing DEX. Genes consistently upregulated by
DEX included MMP7, previously shown to correlate with
chondrocyte maturation [39] and the tissue inhibitor of metallo-
proteinases 4 (TIMP4), known to be upregulated in response to
cartilage injury and degradation [40]. Another example worth
special attention is the WNT-signalling modulator SFRP4, known
to be upregulated during adipogenesis, shown here to be
consistently downregulated by DEX, and upregulated in condi-
tions with BMP2 and no DEX, except where BMP2 was added
alone or with IGF1 only [41]. COL10A1, a known marker of
hypertrophy was consistently and exclusively upregulated in
conditions with TGFb1 [42]. Unlike practically all the other
molecules upregulated by TGFb1, for COL10A1 the absence of
TGFb1 could not be compensated for by the addition of BMP2.
COL2A1, which encodes for the major collagen of hyaline collage,
Figure 4. Heatmap of top ranking conditions. Heatmap of wanted and unwanted genes in all conditions significantly enriched for wanted, but
not unwanted markers, color coded by the studentized score.
doi:10.1371/journal.pone.0096615.g004
Figure 3. Analysis of wanted and unwanted gene expression. A. Gene sets used to compute mean expression of wanted and unwanted
markers. B. Scatter-plot of the mean expression (studentized values) of wanted (x-axis) and unwanted (y-axis) markers at day 0, 1 and 7 of all
conditions. C. Scatter-plot of the mean expression (studentized values) of wanted and unwanted markers at day 0 and 7 for condition 1–32.
doi:10.1371/journal.pone.0096615.g003
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factor, though it is consistently upregulated in all conditions
containing TGFb1 and DEX (Figure S5). Interestingly, FGF2
could be seen to inhibit the upregulatory effect of TGFb1o r
BMP2 on COL2A1 in all conditions where DEX was not also
added. Further substantiating that DEX plays an important role in
chondrogenesis is that PRG4, encoding the surface lubricant
lubricin, was only upregulated in conditions with DEX without
TGFb-superfamily ligands [43](Figure S5).
Genes differentially regulated between key conditions
Finally, we examined genes differentially expressed between key
conditions. In particular, we focused on the effect of adding DEX
to either TGFb1 or to TGFb1+BMP2 (ie. comparing condition 12
to 16 and condition 11 to 15), or adding BMP2 to either TGFb1
or TGFb1+DEX (ie. comparing condition 15 to 16 and condition
11 to 12)(Figure 6A and B and Figure S6). Adding DEX to TGFb1
changed 115 genes significantly, and adding DEX to TGFb1 with
BMP2 changed 110 genes, with an overlap of 77 genes (Figure S7
and Table S3). Several desired genes were upregulated by DEX
such as ACAN, COL2A1 and SOX9 while undesired genes such as
the collagen degrading metallopeptidase MMP13 and the osteo-
genic transcription factor RUNX2 were downregulated by DEX.
As expected, adding BMP2 as the second TGFb-superfamily
signalling molecule to either TGFb1 alone or TGFb1 with DEX
changed only 17 and 14 genes respectively Surprisingly, only the
upregulated gene SOCS2 was common between these gene sets,
showing that DEX importantly affects the way TGFb1 stimulated
MSCs respond to BMP2.
Given that the beneficial effect of DEX has been amply proven,
and IGF1 and FGF2 have been shown to not have effects or even
predominantly negative effects, the remaining question was
whether BMP2 should be added to the combination of TGFb1
and DEX. The answer to this question, at the single gene
expression level, is found in Figure 6D. The most highly
upregulated gene, NOG, encodes a polypeptide noggin that binds
and inactivates BMPs belonging to the TGFb-superfamily,
particularly BMP4 [44,45]. Also the addition of BMP2 on a
background of TGFb1 + DEX leads to downregulation of BMP4
at the mRNA level, which could be a direct effect of BMP2 or
perhaps an effect by noggin also on BMP4 mRNA expression.
NOTCH1, which has been shown to be required in early
chondrogenesis but must be turned off for full chondrogenesis to
occur [30,46], was also downregulated. In addition, several other
downregulated genes such as DPT, FGFR1 and TGFB1 are likely
to have pro-chondrogenic effects [15,47]. One positive effect of
BMP2 was the downregulation of COL3A1, a collagen frequently
coexpressed with type I collagen in connective tissues [48].
In total, these data indicate that addition of BMP2 to a
chondrogenic cocktail already consisting of TGFb1 and DEX will
not improve cartilage formation, at least judging by the expression
of genes of relevance for chondrogenesis.
Discussion
Directed differentiation of stem cells into chondrocytes in vitro
has been shown to require both three-dimensional culture and
environmental ques in the form of growth factors [7,16,17,49].
These cocktails of growth factors have largely been studied by
manipulating one factor at a time, which is laborous and time
consuming. We show here that high-throughput gene profiling
makes it feasible to perform larger scale experiments with
statistical design of experiments, allowing for sound conclusions
on the involvement of many simultaneously investigated factors
[24,50,51].
In the present study we used this approach to dissect the
expression of a chondrogenesis relevant gene set during in vitro
chondrogenesis of MSCs subjected to 48 different conditions of
growth factors and cell densities. We found that only three of the
factors (TGFb1, DEX, and BMP2) directly increased the
expression of chondrogenic markers significantly. Adding FGF2
or IGF1, either alone or in combination with other factors, had
either no effect or predominantly negative effects on the expression
of chondrogenic genes.
TGFb1 is the most extensively used factor for inducing
chondrogenesis in directed differentiation of MSCs [10]. The
present data show that the related factors TGFb2 and 3, but no
single other factor studied here, can replace its positive effects on
chondrogenic differentiation of human MSCs. Next, we found that
adding DEX to TGFb1 changed more that 100 of the investigated
genes significantly, with the vast majority of changes being
favourable for chondrogenesis. This is in line with the use of DEX
in most of the published literature [7,10,14], although a recent
publication actually concluded that DEX should be omitted [52].
The present study extends current knowledge by describing which
of a large set of relevant genes are changed by each of these
factors, and then by two together.
BMPs can, like the TGFb isoforms, promote MSC differenti-
ation into chondrocytes [53,54]. However, BMPs and TGFb have
also been described to exhibit antagonistic activities in many
tissues [55]. We found that both factors increased wanted
chondrogenic markers on their own. Interestingly, the two
combinations identified with the best ratio of wanted to unwanted
genes and highest mean expression of wanted markers contained
both TGFb1 and BMP2. However the effect of adding either
Table 3. Gene set enrichment analysis for wanted and
unwanted markers.
False discovery rate
Condition Wanted Unwanted
11 ,0.0001 0.452
10 ,0.0001 0.273
9 ,0.0001 0.484
12 ,0.0001 0.296
1 ,0.0001 0.135
3 ,0.0001 0.138
13 ,0.0001 0.052
4 ,0.0001 0.080
2 ,0.0001 0.056
5 0.003 0.067
7 0.035 0.051
15 ,0.0001 0.044
14 0.001 0.014
19 0.017 0.018
17 0.020 0.016
29 0.030 0.023
31 0.033 0.023
All conditions enriched for wanted markers are listed and ranked by the false
discovery rate for wanted markers (exact FDR values are not stated for FDR
,0.0001). Conditions enriched for wanted but not for unwanted markers are
marked in bold and stated first.
doi:10.1371/journal.pone.0096615.t003
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PLOS ONE | www.plosone.org 8 May 2014 | Volume 9 | Issue 5 | e96615Figure 5. Genes uniformly affected by single factors across conditions 1–32 at day 7. A. Experimental setup conditions 1–32. B. Heatmap
of genes significantly downregulated in all conditions contaning any one of the factors compared to condition 32. C. Heatmap of genes significantly
upregulated in all conditions contaning any one of the factors compared to condition 32. Values are log2-transformed mean expressions (n = 3).
doi:10.1371/journal.pone.0096615.g005
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on either wanted or unwanted markers. This is most likely
explained by the molecular mechanism for the actions of these
factors. Both BMP2 and TGFb1 are ligands of the transformings
growth factor b superfamily and act by binding to specific type II
receptors, which recruits the corresponding type I receptor,
ultimately leading to phosporylation of receptor-SMADs. Even
though BMP2 works mainly through SMAD1, 5 and 8 and
TGFb1 through SMAD2 and 3, there are known interactions
between the two systems such as the competitive occupation of the
common downstream effector SMAD4 [55]. Also it seems that
adding BMP2 to TGFb1 and DEX does not lead to a significant
upregulation of any genes positively related to chondrogenesis, but
rather to an endogenous modulation of BMP4. Taken together,
there may be more reasons to exclude BMP2 than to include it in a
chondrogenic differentiation cocktail, although it could have a role
in a system with sequential cocktails for different parts of
chondrogenesis, as illustrated by the effect on PRG4. This is in
contrast to findings in the literature that BMP2, -4 or -6 are
beneficial to in vitro chondrogenesis in pellet culture [16,17]. This
finding may be explained by the difference between scaffold based
culture systems such as alginate and pellet or micromass culture
systems. However, the present analysis also included more genes,
and thus was more detailed than the initial experiments leading to
the inclusion of BMPs in the differentiation cocktails used in many,
but not all, labs studying in vitro chondrogenesis.
The FGF2 treatment did not lead to an increase in the
chondrogenic gene expression. On the contrary, a significant
reduction was seen in the general gene expression of both wanted
and unwanted genes when FGF2 was added to the basic
differentiation cocktail. In line with our finding, it has been
published that FGF2 may abolish chondrogenesis when combined
with TGFb1 and BMP-6 [56]. On the other hand, FGF2 has
recently been described to enhance the potential of MSCs for use
in tissue engineering of cartilage when used as a mitogen in the
expansion phase prior to the differentiation [18,57].
We found that IGF1 did not change the general expression of
either wanted or unwanted genes significantly, which is contrary to
some previous publications [21]. IGF1 has been shown to be
expressed in articular cartilage and regulate proteoglycan metab-
olism [58] and it has a distinct expression profile during
embryogenic chondrogenesis [59]. However our finding is in line
with other publications failing to find effects of using IGF1 to
induce chondrogenesis [60,61].
There are limitations to our approach. We only considered gene
expression on the level of transcribed mRNA, which does not
necessarily correlate with protein synthesis [62]. We also utilized a
two-level factorial design with either absence or presence of the
investigated growth factors, which did not allow an assesment of
the role that different factor concentrations might play. Consid-
ering these limitations, we propose that the method presented here
could be adapted to screen large numbers of molecules that could
enhance chondrogenesis. We also believe that the method
described could be valuably expanded to testing several concen-
trations of factors, which would also allow a statistical analysis with
response optimization to be performed [24]. This could be a
particularly valuable way forward, as the concentrations of growth
factors used in the literature rarely are based on complete dose-
response experiments, and they are frequently used without a clear
relation to physiologic concentrations. Recently, screening exper-
iments on large libraries of novel drug-like molecules have also
been performed looking for compounds that increase chondro-
genesis based on simpler initial assays [63]. The approach used in
the present paper could easily be adapted for such a purpose
allowing for the added value of a more stringent selection of new
molecules enhancing wanted but not unwanted genes. Further
supporting the feasibility of our approach in larger screening
experiments is our finding that gene profiling can be performed
directly on lysates without any loss in assay quality. Also the
finding that changes in gene expression seen just one day after
induction predicts later changes, potentially allows for a simpler
design with just one time point, perhaps earlier than the one week
time point chosen in the present study. Combined, the implica-
tions of these findings could decrease both cost and workload
considerably in future experiments. Finally, larger screening
experiments could be efficiently performed in a fractionalized
factorial design allowing for sound conclusions without increasing
the number of experiments [23,64]. However, to test temporal
spatialization of chondrogenic factors to more exactly mirror the
conditions known from embryogenesis of cartilage, the best
approach might be to combine the mRNA profiling assay
Figure 6. Genes significantly regulated between key conditions (day 7). A. Top 20 upregulated and top 20 downregulated genes when
adding DEX to TGFB1. B. Top 20 upregulated and top 20 downregulated genes when adding DEX to TGFB1+BMP2. C. All regulated genes when
adding BMP2 to TGFB1. D. All regulated genes when adding BMP2 to TGFB1+DEX. Values represent log2 to the fold change between the gene
expression in the condition without and the condition with the specified factor added.
doi:10.1371/journal.pone.0096615.g006
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the composition and structure of the ECM [65].
Conclusion
In this study we have shown that high-throughput mRNA
profiling can be efficiently performed on lysates of MSCs during in
vitro chondrogenesis in alginate. A thorough analysis revealed that
the cocktail of growth factors leading to the most efficient
upregulation of wanted chondrogenic markers was a combination
of TGFb and DEX. Adding BMP2 lead to a slightly higher mean
expression of wanted markers but did not significantly upregulate
key positive genes and led to a downregulation of endogenous
BMP4 and TGFb1 expression, and may therefore be expendable.
DEX, on the other hand, worked synergistically with TGFB1 in
increasing wanted marker expression and was also directly
downregulating expression of the unwanted marker BGLAP. All
factors beneficial to the expression of wanted hyaline cartilage
markers also introduced an induction of unwanted markers, with
the exception of DEX alone. Upregulation of COL10A1 was seen
in all conditions containing TGFb1 indicating that perfect
differentiation to hyaline cartilage is not achievable with the
current differentiation protocols.
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